Luyten and colleagues' prospective, randomized, multicenter, double-blind trial, therefore, compared continuous and intermittent celecoxib for the treatment of OA. All 123 patients had a flare of ...

Nearly a decade after reports first surfaced linking the prescription pain reliever celecoxib (Celebrex) to an increased risk of heart attack, and two years after the American Heart Association ...

The interaction of celecoxib and rofecoxib with warfarin was studied. Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Neurosense entered a binding term sheet with a global pharmaceutical company to advance development and commercialization of ...